Richard C. Yocum
2005 - Halozyme Therapeutics
In 2005, Richard C. Yocum earned a total compensation of $220.5K as Vice President — Clinical Development and Medical Affairs at Halozyme Therapeutics.
Compensation breakdown
Non-Equity Incentive Plan | $37,500 |
---|---|
Option Awards | $42,455 |
Salary | $140,430 |
Other | $84 |
Total | $220,469 |
Yocum received $140.4K in salary, accounting for 64% of the total pay in 2005.
Yocum also received $37.5K in non-equity incentive plan, $42.5K in option awards and $84 in other compensation.
Rankings
In 2005, Richard C. Yocum's compensation ranked 186th out of 262 executives tracked by ExecPay. In other words, Yocum earned more than 29.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 186 out of 262 | 29th |
Division Manufacturing | 70 out of 97 | 28th |
Major group Chemicals And Allied Products | 21 out of 29 | 28th |
Industry group Drugs | 16 out of 24 | 33rd |
Industry Biological Products, Except Diagnostic Substances | 6 out of 6 | 0th |
Source: SEC filing on April 3, 2008.
Yocum's colleagues
We found three more compensation records of executives who worked with Richard C. Yocum at Halozyme Therapeutics in 2005.